Add to ORKGIn the present work we classified using genetic signature two subgroups of human pancreatic tumors, based on the expression of ISGs and we demonstrated that this phenotype is indipendent from the microenvironment and is causing a resistance to oncolytic therapies
Pancreatic ductal adenocarcinoma (PDA) is a lethal disease. Overall survival is typically 6 months f...
A recent death projection has placed pancreatic ductal adenocarcinoma as the second cause of death b...
Pancreatic adenocarcinoma presents as a spectrum of a highly aggressive disease in patients. The bas...
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer mortal...
Pancreatic adenocarcinoma (PDAC) is a leading and increasing cause of cancer mortality for which no ...
Background Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer mortality fo...
Immunotherapy has a good therapeutic effect and provides a new approach for cancer treatment. Howeve...
Cancers that appear morphologically similar often have dramatically different clinical features, res...
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest forms of cancer. A major reason for ...
Integrated genomic analysis of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutat...
Pancreatic cancer remains one of the most lethal and poorly understood human malignancies and will c...
Subcloning in pancreatic cancer cell lines of the antiviral phenotype segregation
Pancreatic cancer is a highly fatal disease and an increasing common cause of cancer mortality. Moun...
Objectives: Adenosquamous cancer of pancreas (ASCP) is a rare variant of pancreatic adenocarcinoma (...
Background: Pancreatic adenocarcinoma is one of the most aggressive malignancies with extremely low ...
Pancreatic ductal adenocarcinoma (PDA) is a lethal disease. Overall survival is typically 6 months f...
A recent death projection has placed pancreatic ductal adenocarcinoma as the second cause of death b...
Pancreatic adenocarcinoma presents as a spectrum of a highly aggressive disease in patients. The bas...
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer mortal...
Pancreatic adenocarcinoma (PDAC) is a leading and increasing cause of cancer mortality for which no ...
Background Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer mortality fo...
Immunotherapy has a good therapeutic effect and provides a new approach for cancer treatment. Howeve...
Cancers that appear morphologically similar often have dramatically different clinical features, res...
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest forms of cancer. A major reason for ...
Integrated genomic analysis of 456 pancreatic ductal adenocarcinomas identified 32 recurrently mutat...
Pancreatic cancer remains one of the most lethal and poorly understood human malignancies and will c...
Subcloning in pancreatic cancer cell lines of the antiviral phenotype segregation
Pancreatic cancer is a highly fatal disease and an increasing common cause of cancer mortality. Moun...
Objectives: Adenosquamous cancer of pancreas (ASCP) is a rare variant of pancreatic adenocarcinoma (...
Background: Pancreatic adenocarcinoma is one of the most aggressive malignancies with extremely low ...
Pancreatic ductal adenocarcinoma (PDA) is a lethal disease. Overall survival is typically 6 months f...
A recent death projection has placed pancreatic ductal adenocarcinoma as the second cause of death b...
Pancreatic adenocarcinoma presents as a spectrum of a highly aggressive disease in patients. The bas...